time
book
review
major
advanc
field
bacteri
vaccin
made
possibl
increas
number
whole
genom
sequenc
bacteri
pathogen
determin
last
year
follow
introductori
chapter
ruth
arnon
weizmann
institut
describ
variou
vaccin
strategi
use
microbi
diseas
chapter
rino
rappuoli
colleagu
novarti
vaccin
siena
give
comprehens
overview
new
approach
known
revers
vaccinolog
approach
introduc
ten
year
ago
call
revers
vaccinolog
search
vaccin
candid
classic
approach
fraction
bacteri
extract
establish
antigen
abl
induc
protect
immun
respons
predict
potenti
vaccin
immunogen
use
bioinformat
analys
entir
bacteri
genom
silico
analysi
genom
provid
list
antigen
pathogen
abl
express
allow
investig
choos
revers
manner
start
genom
rather
organ
potenti
surfaceexpos
protein
investig
surfac
protein
express
use
highthroughput
technolog
test
immunoreact
patient
sera
immunogen
protect
studi
chapter
also
describ
variou
techniqu
use
revers
vaccinolog
silico
antigen
predict
protein
identif
mass
spectrometri
highthroughput
antigen
gener
use
anim
model
test
protect
efficaci
method
use
test
immunogen
vaccin
candid
compar
earlier
approach
alway
restrict
small
number
purifi
antigen
revers
vaccinolog
identifi
hundr
protein
potenti
vaccin
candid
test
immunogen
protect
efficaci
anoth
advantag
strategi
use
microorgan
cultiv
one
chapter
book
devot
first
success
applic
new
approach
name
develop
vaccin
meningococcu
b
men
b
pathogen
caus
meningococc
mening
worldwid
total
predict
open
read
frame
genom
select
potenti
surfaceexpos
success
clone
e
coli
purifi
suffici
amount
immun
mice
analysi
mous
sera
reveal
previous
unknown
surfac
locat
protein
abl
induc
antibodi
kill
bacteria
presenc
complement
earlier
studi
surfac
antigen
meningococcu
describ
shown
possess
bactericid
activ
phase
iii
clinic
trial
men
b
vaccin
effect
meningococc
strain
current
underway
chapter
book
devot
bacteri
toxin
glycoconjug
chemistri
novel
adjuv
intralymphat
vaccin
develop
vaccin
infect
caus
pseudomona
aeruginosa
staphylococcu
aureu
streptococcu
pneumonia
one
chapter
entir
devot
develop
viral
vaccin
name
sever
acut
respiratori
syndrom
coronaviru
sarscov
howev
variou
part
book
suggest
futur
revers
vaccinolog
togeth
structur
biolog
may
use
develop
vaccin
hepat
c
viru
human
rotaviru
human
immunodefici
viru
note
virologist
tend
use
term
revers
vaccinolog
differ
way
one
use
book
follow
denni
burton
nat
rev
immunol
virologist
use
term
refer
strategi
gener
vaccin
known
crystallograph
structur
neutral
monoclon
antibodi
rather
usual
revers
approach
gener
protect
antibodi
immun
attempt
gener
vaccin
type
revers
vaccinolog
use
crystal
structur
epitop
bound
antibodi
fail
far
possibl
extrapol
antigen
structur
observ
antigenantibodi
complex
immunogen
structur
need
vaccin
unfortun
algorithm
predict
protect
vaccin
epitop
either
bacteri
viral
genom
possibl
predict
whether
structur
defin
antigen
site
use
immunogen
give
rise
neutral
antibodi
compar
virus
howev
bacteri
pathogen
advantag
express
much
larger
number
antigen
evalu
potenti
vaccin
immunogen
nevertheless
book
show
end
empir
trialanderror
experiment
still
way
discov
bacteri
protein
combin
make
effect
bacteri
vaccin
book
essenti
read
microbiologist
vaccinologist
want
acquaint
new
approach
use
develop
bacteri
vaccin
